Joshua D. Milner

Joshua D. Milner publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Joshua D. Milner sits on this spectrum.

Joshua D. Milner D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Joshua D. Milner sits on this spectrum.

Overview

Best Publications

• Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

  Qian Zhang;Paul Bastard;Paul Bastard;Zhiyong Liu;Jérémie Le Pen

  2199
  Citations

• Impaired T H 17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

  Joshua D. Milner;Jason M. Brenchley;Jason M. Brenchley;Arian Laurence;Alexandra F. Freeman

  1653
  Citations

• Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

  Qing Zhou;Dan Yang;Amanda K Ombrello;Andrey V Zavialov

  920
  Citations

• Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources

  Sebastian Köhler;Leigh Carmody;Nicole A. Vasilevsky;Julius O. B. Jacobsen

  715
  Citations

• Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease

  Qing Zhou;Hongying Wang;Daniella M. Schwartz;Monique Stoffels

  622
  Citations

• Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City.

  Eva W. Cheung;Philip Zachariah;Mark Gorelik;Alexis Boneparth

  611
  Citations

• Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations

  Joshua D. Milner;Tiphanie P. Vogel;Lisa Forbes;Chi A. Ma

  599
  Citations

• Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

  Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  592
  Citations

• Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

  Julie Toubiana;Satoshi Okada;Satoshi Okada;Julia Hiller;Matias Oleastro

  553
  Citations

• Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.

  Stuart P. Weisberg;Thomas J. Connors;Yun Zhu;Matthew R. Baldwin

  528
  Citations

• Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions.

  Michael J. Ombrello;Elaine F. Remmers;Guangping Sun;Alexandra F. Freeman

  448
  Citations

• A Hypermorphic Missense Mutation in PLCG2, Encoding Phospholipase Cγ2, Causes a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency

  Qing Zhou;Geun-Shik Lee;Geun-Shik Lee;Jillian Brady;Shrimati Datta

  408
  Citations

• Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number.

  Jonathan J Lyons;Xiaomin Yu;Jason D Hughes;Quang T Le

  374
  Citations

• A Critical Role for STAT3 Transcription Factor Signaling in the Development and Maintenance of Human T Cell Memory

  Andrea M. Siegel;Jennifer Heimall;Alexandra F. Freeman;Amy P. Hsu

  324
  Citations

• Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.

  Gulbu Uzel;Elizabeth P. Sampaio;Monica G. Lawrence;Amy P. Hsu

  323
  Citations

• Atopic dermatitis in children: clinical features, pathophysiology, and treatment.

  Jonathan J. Lyons;Joshua D. Milner;Kelly D. Stone

  300
  Citations

• Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome

  Daniel Kotlarz;Natalia Ziętara;Gulbu Uzel;Thomas Weidemann

  274
  Citations

• Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease

  Qing Zhou;Xiaomin Yu;Erkan Demirkaya;Natalie Deuitch

  265
  Citations

• Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment

  Yu Zhang;Xiaomin Yu;Mie Ichikawa;Jonathan J. Lyons

  263
  Citations

• Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations.

  Lisa R. Forbes;Tiphanie P. Vogel;Megan A. Cooper;Johana Castro-Wagner

  254
  Citations

• Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis

  Elizabeth P. Sampaio;Elizabeth P. Sampaio;Amy P. Hsu;Joseph Pechacek;Hannelore I. Bax;Hannelore I. Bax

  253
  Citations

• Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection.

  Nichole R. Klatt;Jacob D. Estes;Xiaoyong Sun;Alexandra M. Ortiz;Alexandra M. Ortiz

  235
  Citations